Exalenz Bioscience Ltd Share Price
Equities
EXEN
IL0011048688
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- ILa | -.--% | +1.39% | +107.88% |
Sales 2018 | 13.14M 3.45M 1.31B 288M | Sales 2019 | 14.04M 3.69M 1.4B 308M | Capitalization | 77.67M 20.41M 7.77B 1.7B |
---|---|---|---|---|---|
Net income 2018 | -5M -1.31M -500M -110M | Net income 2019 | -1M -263K -100M -21.91M | EV / Sales 2018 | 15.2 x |
Net Debt 2018 | 2.93M 769K 293M 64.12M | Net Debt 2019 | 3.09M 813K 309M 67.75M | EV / Sales 2019 | 5.75 x |
P/E ratio 2018 |
-34.6
x | P/E ratio 2019 |
-40
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 24.36% |
Managers | Title | Age | Since |
---|---|---|---|
Raffi Werner
CEO | Chief Executive Officer | 65 | 01/10/01 |
Moshe Dori
DFI | Director of Finance/CFO | - | 29/19/29 |
Eitan Blank
COO | Chief Operating Officer | 53 | 01/07/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Kochan
BRD | Director/Board Member | 55 | 04/16/04 |
Moshe Arkin
BRD | Director/Board Member | 69 | 01/06/01 |
Hanna Lerman
BRD | Director/Board Member | 51 | 16/15/16 |
1st Jan change | Capi. | |
---|---|---|
+107.88% | 45.97M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- EXEN Stock